Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Atreca, Inc. (BCEL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/04/2023 |
4
| Serafini Tito (Chief Strategy Officer) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 5,487 shares
@ $0.9522, valued at
$5.2k
|
|
08/04/2023 |
4
| CROSS HERB (CFO) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 5,487 shares
@ $0.9522, valued at
$5.2k
|
|
08/04/2023 |
4
| Gould Stephen E (Chief Scientific Officer) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 4,076 shares
@ $0.9522, valued at
$3.9k
|
|
08/04/2023 |
4
| Courtney Phillips (General Counsel & Secretary) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 4,076 shares
@ $0.9522, valued at
$3.9k
|
|
06/15/2023 |
4
| Rolfe Lindsey (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| Robinson William Hewitt (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| Ma Stacey (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| Lacey David L. (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| Brady Stephen R (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| BALL KRISTINE M (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
06/15/2023 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2023 |
4
| Bishop Philippe C (Chief Medical Officer) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 350,000 options to buy
@ $1.37, valued at
$479.5k
|
|
01/11/2023 |
3
| Bishop Philippe C (Chief Medical Officer) has filed a Form 3 on Atreca, Inc. |
09/20/2022 |
4
| Serafini Tito (Chief Strategy Officer) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 7,646 shares
@ $1.7752, valued at
$13.6k
|
|
09/20/2022 |
4
| Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 20,908 shares
@ $1.7752, valued at
$37.1k
|
|
09/20/2022 |
4
| CROSS HERB (CFO) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 7,646 shares
@ $1.7752, valued at
$13.6k
|
|
09/20/2022 |
4
| Courtney Phillips (General Counsel & Secretary) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 6,432 shares
@ $1.7752, valued at
$11.4k
|
|
06/30/2022 |
4
| Serafini Tito (Chief Strategy Officer) has filed a Form 4 on Atreca, Inc.
Txns:
| Sold 15,000 shares
@ $2.0177, valued at
$30.3k
|
|
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/15/2022 |
4
| Courtney Phillips (General Counsel & Secretary) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 80,000 options to buy
@ $1.845, valued at
$147.6k
Disposed/sold 80,000 options to buy
@ $13.97, valued at
$1.1M
Granted 45,000 options to buy
@ $1.845, valued at
$83k
Disposed/sold 45,000 options to buy
@ $16.74, valued at
$753.3k
Granted 91,666 options to buy
@ $1.845, valued at
$169.1k
Disposed/sold 91,666 options to buy
@ $17, valued at
$1.6M
Granted 65,000 options to buy
@ $1.845, valued at
$119.9k
Disposed/sold 65,000 options to buy
@ $22.07, valued at
$1.4M
|
|
06/15/2022 |
4
| Serafini Tito (Chief Strategy Officer) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 95,000 options to buy
@ $1.845, valued at
$175.3k
Disposed/sold 95,000 options to buy
@ $13.97, valued at
$1.3M
Granted 88,000 options to buy
@ $1.845, valued at
$162.4k
Disposed/sold 88,000 options to buy
@ $22.07, valued at
$1.9M
Granted 141,395 options to buy
@ $1.845, valued at
$260.9k
Disposed/sold 141,395 options to buy
@ $10.02, valued at
$1.4M
Granted 50,145 options to buy
@ $1.845, valued at
$92.5k
Disposed/sold 50,145 options to buy
@ $10.02, valued at
$502.5k
|
|
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| BALL KRISTINE M (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $2.09, valued at
$25.1k
|
|
06/10/2022 |
4
| Brady Stephen R (Director) has filed a Form 4 on Atreca, Inc.
Txns:
| Granted 12,000 options to buy
@ $2.09, valued at
$25.1k
|
|
|
|
|